Skip to Content

mCOMBRIAX dispersion for injection in pre-filled syringe. Influenza and COVID-19, mRNA vaccine.

Licence status
Authorised: 20/04/2026
Active substances
mRNA encoding Influenza A, H1N1 strain, hemagglutinin glycoprotein, mRNA encoding Influenza A, H3N2 strain, hemagglutinin glycoprotein, mRNA encoding Influenza B/Victoria, hemagglutinin glycoprotein, mRNA-1283
Dosage Form
Dispersion for injection in pre-filled syringe
Licence number
EU/1/26/2028/001-002
Licence holder
Moderna Biotech Spain S.L.

Licence information

ATC code
J07B VIRAL VACCINES
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Official batch release In accordance with Article 114 of Directive 2001/83/EC, the official batch release will be undertaken by a state laboratory or a laboratory designated for that purpose.
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
20/04/2026